Skip to content
GLP-1 Decoder

Victoza FDA Approval: Every Indication and Date

Fda Victoza: what happened, what it means for patients, and where to read the record.

Active ingredient
liraglutide
Manufacturer
Novo Nordisk
How it is taken
Daily injection
FDA-approved for
Type 2 diabetes, Heart risk

Victoza facts at a glance

How long it remains in your body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

Its half-life lasts about 13 hours. After 13 h, half is gone; after five half-lives (2.7 d), about 3% remains.

Weight loss in the main trial
Victoza (LEAD-3)2.5 kgPlacebo1.1 kg

In the 52-week LEAD-3 trial for type 2 diabetes, 2.5 kg was lost, compared with 1.1 kg on placebo.

Sources: FDA label (DailyMed).